Nucleolus-Targeting Carbon Dot Nanocomplexes for Combined Photodynamic/Photothermal Therapy
Molecular Pharmaceutics · 03.02.2025 · 22 (2) · 958-971
DOI: 10.1021/acs.molpharmaceut.4c01211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 30.12.2024. Verfasst von Shaofang Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science and Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan 030001, China. Hauptthemen laut MEDLINE: Photochemotherapy, Carbon, Photothermal Therapy, Quantum Dots. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Shanxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The low cure rate and high mortality associated with cancer pose significant threats to human health. Photodynamic and photothermal therapies have emerged as promising treatment strategies for various types of cancers. In this study, we successfully synthesized a novel type of carbon dot (CD) using 1,2,4-aminobenzene and ethylenediamine as precursors. Surprisingly, these CDs exhibited outstanding nucleolus-targeting capabilities coupled with a remarkable photothermal effect. Through the integration of these nucleolus-targeting CDs with indocyanine green (ICG) and folic acid (FA), we created CDs-ICG-FA nanocomplexes suitable for combined photodynamic and photothermal therapy. In vitro experiments demonstrated that CDs-ICG-FA maintained a robust photothermal ability, achieving a conversion efficiency of up to 34.3%. Furthermore, CDs-ICG-FA generated abundant reactive oxygen species, effectively inducing cancer cell death and demonstrating its potential for photodynamic therapy. In MCF-7 cancer cells, CDs-ICG-FA exhibited a pronounced synergistic photothermal/photodynamic anticancer effect. Subsequent in vivo experiments in mice revealed that CDs-ICG-FA could selectively accumulate at tumor sites, significantly inhibiting tumor growth upon exposure to an 808 nm laser. These findings suggest that the developed nucleolus-targeting CDs-ICG-FA hold promising potential for cancer targeting and the application of combined photothermal/photodynamic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Science and Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan 030001, China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
ORCID-Profile: Xin Zhou, Jing Wang, Wei Bian, Xinjing Tang
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Shanxi Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, S., Zhang, Y., Zhu, Z., Wang, D., Zhou, X., Wang, J., Bian, W., & Tang, X. (2025). Nucleolus-Targeting Carbon Dot Nanocomplexes for Combined Photodynamic/Photothermal Therapy. Molecular Pharmaceutics, 22(2), 958-971. https://doi.org/10.1021/acs.molpharmaceut.4c01211
Vancouver
Ma S, Zhang Y, Zhu Z, Wang D, Zhou X, Wang J, et al. Nucleolus-Targeting Carbon Dot Nanocomplexes for Combined Photodynamic/Photothermal Therapy. Molecular Pharmaceutics. 2025;22(2):958-971. doi:10.1021/acs.molpharmaceut.4c01211
BibTeX
@article{Ma2025,
author = {Ma, Shaofang and Zhang, Yan and Zhu, Zihan and Wang, Deping and Zhou, Xin and Wang, Jing and Bian, Wei and Tang, Xinjing},
title = {Nucleolus-Targeting Carbon Dot Nanocomplexes for Combined Photodynamic/Photothermal Therapy},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {2},
pages = {958--971},
doi = {10.1021/acs.molpharmaceut.4c01211}
}
EUVIMED